SWK Holdings Corporation Acquires Enteris BioPharma

SWK Holdings Corporation acquires 100% of Enteris’ equityEnteris to operate as an independent, wholly-owned subsidiary of SWK, targeting opportunities to develop and advance orally delivered peptide and small molecule therapeuticsNatural extension of SWK’s life...